PAD patients were more likely to have hs-cTnT levels above the limit of detection than controls, and hs-cTnT concentrations were highly significantly related to prevalent cardiovascular disease and independently predicted MACE and all-cause mortality over a 7-year follow-up. This evidence concerns the gene TNNT2 and cardiovascular disorder.